Operationalisation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 trials in a low and lower-middle income critical care learning health system
The Randomized Embedded Multifactorial Adaptive Platform (REMAP-CAP) adapted for COVID-19) trial is a global adaptive platform trial of hospitalised patients with COVID-19. We describe implementation in three countries under the umbrella of the Wellcome supported Low and Middle Income Country (LMIC)...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Journal article |
語言: | English |
出版: |
F1000 Research
2021
|